Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Aug 20 424B2 Prospectus for primary offering
- 4 Aug 20 FWP Free writing prospectus
- 3 Aug 20 FWP Free writing prospectus
- 3 Aug 20 424B2 Prospectus for primary offering
-
8 Nov 19 F-3ASR Automatic shelf registration (foreign)
AZN similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
AstraZeneca PLC:
We consent to the use of our report dated 2 February, 2017, with respect to the consolidated statement of financial position of AstraZeneca PLC and subsidiaries as of 31 December 2016, and the related consolidated statements of comprehensive income, changes in equity, and cash flows for the year then ended, and the related notes (collectively, the “consolidated financial statements”), incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
KPMG LLP
London
United Kingdom
8 November 2019